MedTrace Logo

The Effectiveness of the Logic Back™Support.

NCT00754585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2010-11-17

No results posted yet for this study

Summary

Back pain and chair use are the second most important health factors for the aging workforce. Besides personal suffering, postural discomfort in the workplace reduces performance and productivity, both of which can be improved by raising comfort levels. In an attempt to improve comfort and reduce injury risk, ergonomic chairs are commonly equipped with lumbar supports in an attempt to support a "neutral" spine. However, people often alter their position when such a device is in place as they arch their back to conform to it. The Logic Back support offers a simple means to alter posture and reduce associated strain on the lower back during seated tasks by supporting the "Effortless Neutral Position" or the natural curvature of the low back. Although it has been used clinically by many practitioners, its effectiveness has yet to be shown by scientific study. The current work will help to understand if and why the Logic Back is effective and how it can become a low-cost solution to reduce the discomfort of those suffering from low back pain.

The purpose of this study is to determine the effectiveness of the Logic Back and the "Effortless Neutral Position" in improving comfort and functional performance during seated tasks, as compared to a standard, ergonomic chair.

Conditions

  • Low Back Pain
  • Posture

Interventions

DEVICE

Logic Back Grahl Duo Back Model DB11-01

The device is placed against the back rest of a chair. The tension of the straps are adjusted for each participant to obtain the ENP.

Sponsors & Collaborators

  • Logic Back

    collaborator UNKNOWN

  • McMaster University

    collaborator OTHER

  • Canadian Memorial Chiropractic College

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00754585 on ClinicalTrials.gov